|
krabbe's disease
Krabbe's disease--globoid cell leukodystrophy]
 Krabbe disease is a rare, degenerative disorder of the central and peripheral nervous systems.
 It is one of a group of genetic disorders called the leukodystrophies that affect the growth of the myelin sheath,
 the fatty covering—which acts as an insulator—on nerve fibers in the brain
 . Symptoms vary in prevalence and severity among patients and may include
 loss of previously attained developmental skills,
 unexplained fevers,
 irritability,
 myoclonic seizures (sudden, shock-like contractions of the limbs),
 blindness,
 spasticity (stiffness of the limbs),
 and paralysis.
 Prolonged weight loss may occur also.
 Onset of the disorder generally occurs at 3 to 6 months of age.
TREATMENT:
 There is no cure for Krabbe disease.
 Treatment for the disorder is symptomatic and supportive
 . Physical therapy may help maintain or increase muscle tone and circulation.
 PROGNOSIS:
 The prognosis for individuals with Krabbe disease is poor.
 The disorder is generally fatal before age 2.
Globoid-cell leukodystrophy (Krabbe disease) is a rapidly progressive, invariably fatal disease of infants.
It is transmitted as an autosomal recessive trait.
The disease usually begins between ages 3 and 6 months
with ambiguous symptoms, such as
irritability
or hypersensitivity to external stimuli,
but soon progresses to severe mental and motor deterioration.
Patients rarely survive the second year.
Clinical manifestations are limited to the nervous system with prominent long-tract signs.
There is hypertonicity with hyperactive reflexes in the early stages,
but patients later become flaccid and hypotonic.
Blindness and deafness are common.
Peripheral neuropathy is almost always detectable.
The clinical picture of the classic infantile form is relatively uniform, but atypical or late-onset forms of the disease are known.
The presence of numerous multinucleated globoid cells, almost total loss of myelin and oligodendroglia, and astrocytic gliosis in the white matter are the morphologic bases for diagnosis.
The globoid cells are hematogenous macrophages that contain undigested galactocerebroside.
Segmental demyelination, axonal degeneration, fibrosis, and macrophage infiltration are common in the peripheral nervous system.
Consistent with the myelin loss, the white matter is severely depleted of all lipids, particularly glycolipids.
The ratio of galactocerebroside to sulfatide is abnormally high.
Galactocerebroside (galactosylceramide) is a sphingoglycolipid consisting of
sphingosine,
fatty acid,
and galactose,
and is normally present almost exclusively in the myelin sheath.
The cause of Krabbe disease is a genetic deficiency of galactosylceramidase (galactocerebroside b-galactosidase).
This lysosomal enzyme normally degrades galactocerebroside to ceramide and galactose.
It is postulated that accumulation of a toxic metabolite, psychosine (galactosylsphingo sine), which is also a substrate for the missing enzyme, leads to early destruction of the oligodendroglia.
The total brain content of galactocerebroside is not increased.
However, the extensive globoid-cell reaction indicates that impaired catabolism of galactosylceramide is also an important factor in the pathogenesis.
Assays of galactosylceramidase in leukocytes or cultured fibroblasts with the use of appropriate natural glycolipid substrates can establish definitive antemortem diagnosis.
There is no effective therapy, but preventive measures are available through intrauterine diagnosis of affected fetuses by galactosylceramidase assays on amniotic fluid cells or biopsied chorionic villi.
The human galactosylceramidase gene has been mapped to chromosome 14.
However, the cDNA or the gene coding for galactosylceramidase has not been cloned;
thus, nucleic acid level information is not yet available
Globoid-cell leukodystrophy, also due to genetic galactosyl ceramidase deficiency, occurs in other mammalian species, most notably in certain strains of dogs and mice. Clinical and pathological features are similar to those in the human disease. These animal models are invaluable tools for studies of this rare genetic disease.
|
Galactosylceramide Lipoidosis (Krabbe)
l Galactosylceramide b-galactosidase ; Chromosome 14q31; Recessive
 Childhood
 CNS
 Mental retardation
 Optic Atrophy
 Tone: Spasticity; Hypertonia (Occasional hypotonia)
 Polyneuropathy
 ê Tendon reflexes
 Electrophysiology: Nerve conduction velocities slow
 Later-onset (> 10 years (13 to 38)) forms
 Spasticity: Legs & Bladder
 Polyneuropathy: Predominantly motor
 Other CNS signs: Dysarthria; Optic atrophy
 MRI: Corticospinal tract & periventricular demyelination
 Genetics
 Most mutations in region coding for 50 kDa subunit
 Occasional mutations in 30 kDa subunit
 CSF: High Protein
 Electrophysiology: Demyelinating Neuropathy; Slow NCV
Pathology
 Hypomyelination of axons
 Inclusions
 Locations: Schwann cells; Histiocytes
 Structure
 Shape: Straight or Slightly curved, Crystalloid & Prismatic
 Contents: Clear & empty on paraffin & ultrastructure
 Rare onion bulbs
 Axonal loss
|